Disease | hemolytic anemia |
Comorbidity | C0270612|leukoencephalopathy |
Sentences | 1 |
PubMedID- 20678204 | A phase i strategy of dual inhibition using sunitinib and bevacizumab in renal cell carcinoma was complicated by the development of frequent severe hypertension and microangiopathic hemolytic anemia associated with reversible posterior leukoencephalopathy syndrome [69]. |
Page: 1